Search

everythinglearnresearchcommunity

for

Search:↓

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Understanding testosterone and estradiol levels is crucial for identifying normal and abnormal hormone levels in men, especially as they age.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Eating alfalfa sprouts every day can raise testosterone levels in middle-aged men, but broccoli sprouts don't have this effect.

Hormone levels change during puberty, leading to physical developments like pubic hair and voice changes.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

High androgen levels often cause female hirsutism and infertility.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Normal androgen levels need ACTH, and different mechanisms control adrenarche and gonadarche.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Testosterone levels aren't important for depression in men, but some other hormones might affect certain symptoms.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Oriental men may have lower androgen activity affecting hair growth despite similar testosterone levels to Caucasian men.

The method accurately measures seven androgens in plasma and shows different hormone levels in females with acne and obesity.

Higher DHEA-S levels in hirsute females affect hair growth phases.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

New treatments for androgenetic alopecia show promise but need more research for validation.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

High TNF-α levels may increase hair loss risk after PRP therapy.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.